ANNOVIS BIO INC. COMM

Annovis Bio Announces Issuance of U.S. Patent Covering the Use of Lead Drug Candidate, Buntanetap, for Prevention or Treatment of Disease States Due to Metal Dis-Homeostasis in Healthy or Sick Humans

27 апр 2023 07:00:00 Источник Nasdaq GlobeNewswire

Annovis Bio, Inc. to present at the Q1 Virtual Investor Summit 

11 мар 2021 07:05:00 Источник Nasdaq GlobeNewswire

Annovis Bio to Present at the BIO CEO & Investor Digital Conference

16 фев 2021 06:45:00 Источник Nasdaq GlobeNewswire